Comparison of two ways of delivering a drug (progesterone) to prevent another preterm delivery, one by an injection and other through the vagina

Not Applicable

• Conditions: Health Condition 1: null- Pregnant patients with a prior spontaneous preterm birth or mid trimester abortion

• Registration Number: CTRI/2015/01/005467
• Lead Sponsor: Postgraduate Institute of Medical Education and Research

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: Closed to Recruitment of Participants
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

1. Women with a singleton pregnancy between 16 to 24 weeks

2. Women with at least one spontaneous second trimester abortion or preterm birth ( >16 weeks to <37 weeks) of a singleton infant due to spontaneous preterm labour or pProm

Exclusion Criteria

1. Multifetal Gestation

2. Known allergy to progesterone.

3. Women with known medical disorders (Chronic Hypertension, Diabetes mellitus, heart disease) which may need preterm delivery

4. Lethal congenital malformation of the fetes

Study & Design

• Study Type: Interventional
• Study Design: Not specified